Pfizer reports phase 2 data for 25-valent pneumococcal vaccine
In
Investing.comBy Investing.com10/24/2026, 3:24:42 PM
EXECUTIVE SUMMARY
Pfizer reports phase 2 data for 25-valent pneumococcal vaccine....
Key Takeaways
- Pfizer reports phase 2 data for 25-valent pneumococcal vaccine.
Read Complete Original Article
Published originally on Investing.com
Related News
finance22 minutes ago
Form 4 YPF SOCIEDAD ANONIMA: Tanoira Santiago Martinez (LNG & Integr. Gas Exec. VP) For: 1 October - Investing.com Australia
Form 4 YPF SOCIEDAD ANONIMA: Tanoira Santiago Martinez (LNG & Integr. Gas Exec. VP) For: 1 October Investing.com Australia
finance34 minutes ago
Iran has ramped up efforts to target US personnel, intelligence memo warns
Iran has ramped up efforts to target US personnel, intelligence memo warns....
finance52 minutes ago
Form 4 Murphy Oil Corporation: Jeffrey W. Nolan (Director) For: 30 September - Investing.com Australia
Form 4 Murphy Oil Corporation: Jeffrey W. Nolan (Director) For: 30 September Investing.com Australia
finance52 minutes ago
Form 144 PROCTER & GAMBLE Co For: 24 October By Investing.com - Investing.com Australia
Form 144 PROCTER & GAMBLE Co For: 24 October By Investing.com Investing.com Australia
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!